Goat
Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; Caprinae; Capra,
Latin Name:
Capra aegagrus hircus
Tested tissues: Lung, PBMC,
Data set information
| Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
|---|---|---|---|---|---|---|
| Vthunter_0047 | 2021.04 | 10X Genomics | Lung | Normal | 4681 | Link |
| Vthunter_100007 | 2021.05 | 10X Genomics | PBMC | Normal | 1043 | Link |
| Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
|---|---|---|
|
Middle East respiratory syndrome-related coronavirus |
Lung-Mesothelial cells : 100.00% ; Lung-Ciliated cells : 68.59% ; Lung-Endothelial cells : 48.44% ; |
|
Severe acute respiratory syndrome coronavirus 2 |
Lung-ATI : 94.50% ; Lung-Fibroblasts : 87.08% ; Lung-Smooth muscle cells : 85.78% ; Lung-Ciliated cells : 81.53% ; Lung-Secretory cells : 79.79% ; Lung-Ciliated cells : 57.31% ; Lung-Endothelial cells : 39.64% ; Lung-Secretory cells : 36.27% ; Lung-Macrophages : 27.77% ; Lung-Ciliated cells : 39.57% ; Lung-Dendritic cells : 37.50% ; Lung-Macrophages : 25.32% ; Lung-Smooth muscle cells : 24.83% ; |
|
Rhinovirus C |
Lung-Ciliated cells : 93.05% ; |
|
Influenza A virus |
Lung-ATII : 91.15% ; Lung-Ciliated cells : 90.89% ; Lung-Secretory cells : 86.01% ; Lung-Mesothelial cells : 84.62% ; Lung-ATI : 83.70% ; Lung-Ciliated cells : 90.41% ; Lung-ATI : 89.62% ; Lung-Dendritic cells : 87.50% ; Lung-Secretory cells : 83.94% ; Lung-Natural killer cells : 81.82% ; Lung-Ciliated cells : 77.70% ; Lung-Mesothelial cells : 53.85% ; Lung-ATI : 48.81% ; Lung-Fibroblasts : 37.64% ; Lung-Macrophages : 31.22% ; Lung-Ciliated cells : 31.89% ; Lung-Fibroblasts : 29.78% ; |
|
Hepacivirus C |
Lung-ATII : 91.15% ; Lung-Ciliated cells : 90.89% ; Lung-Secretory cells : 86.01% ; Lung-Mesothelial cells : 84.62% ; Lung-ATI : 83.70% ; Lung-Ciliated cells : 60.91% ; Lung-Dendritic cells : 50.00% ; Lung-Mesothelial cells : 38.46% ; Lung-T cells : 32.79% ; Lung-Secretory cells : 30.05% ; Lung-Ciliated cells : 60.67% ; Lung-ATI : 34.48% ; Lung-Macrophages : 32.66% ; Lung-Secretory cells : 32.64% ; Lung-Dendritic cells : 25.00% ; Lung-Ciliated cells : 58.51% ; Lung-ATI : 33.13% ; Lung-Secretory cells : 23.32% ; Lung-Ciliated cells : 57.31% ; Lung-Endothelial cells : 39.64% ; Lung-Secretory cells : 36.27% ; Lung-Macrophages : 27.77% ; Lung-Ciliated cells : 50.60% ; Lung-ATII : 38.53% ; Lung-Macrophages : 24.75% ; Lung-Secretory cells : 23.32% ; |
|
Human betaherpesvirus 5 |
Lung-ATII : 91.15% ; Lung-Ciliated cells : 90.89% ; Lung-Secretory cells : 86.01% ; Lung-Mesothelial cells : 84.62% ; Lung-ATI : 83.70% ; Lung-Ciliated cells : 81.30% ; Lung-ATI : 64.69% ; Lung-Dendritic cells : 62.50% ; Lung-Fibroblasts : 60.67% ; Lung-Secretory cells : 54.40% ; Lung-Ciliated cells : 65.95% ; Lung-ATI : 46.31% ; Lung-Fibroblasts : 39.33% ; PBMC-T cells : 39.22% ; Lung-Secretory cells : 38.34% ; Lung-Ciliated cells : 62.59% ; Lung-ATII : 51.51% ; Lung-Mesothelial cells : 38.46% ; Lung-Secretory cells : 37.82% ; Lung-Fibroblasts : 32.58% ; |
|
Vesicular stomatitis virus | |
|
Gibbon ape leukemia virus |
Lung-Ciliated cells : 86.57% ; Lung-ATI : 50.16% ; Lung-Secretory cells : 47.15% ; Lung-Mesothelial cells : 46.15% ; Lung-Fibroblasts : 40.45% ; Lung-Ciliated cells : 60.19% ; Lung-Mesothelial cells : 38.46% ; Lung-Natural killer cells : 36.36% ; PBMC-NKs : 35.71% ; PBMC-B cells : 33.52% ; |
|
Feline leukemia virus strain B/lambda-B1 |
Lung-Ciliated cells : 86.57% ; Lung-ATI : 50.16% ; Lung-Secretory cells : 47.15% ; Lung-Mesothelial cells : 46.15% ; Lung-Fibroblasts : 40.45% ; Lung-Ciliated cells : 60.19% ; Lung-Mesothelial cells : 38.46% ; Lung-Natural killer cells : 36.36% ; PBMC-NKs : 35.71% ; PBMC-B cells : 33.52% ; |
|
Amphotropic murine leukemia virus |
Lung-Ciliated cells : 86.57% ; Lung-ATI : 50.16% ; Lung-Secretory cells : 47.15% ; Lung-Mesothelial cells : 46.15% ; Lung-Fibroblasts : 40.45% ; |
|
Foot-and-mouth disease virus |
Lung-Ciliated cells : 85.61% ; Lung-Mesothelial cells : 84.62% ; Lung-Secretory cells : 79.27% ; Lung-ATI : 67.91% ; Lung-ATII : 60.56% ; Lung-Ciliated cells : 81.30% ; Lung-ATI : 64.69% ; Lung-Dendritic cells : 62.50% ; Lung-Fibroblasts : 60.67% ; Lung-Secretory cells : 54.40% ; Lung-Ciliated cells : 72.18% ; Lung-Secretory cells : 62.69% ; Lung-ATI : 49.53% ; Lung-ATII : 45.17% ; Lung-Dendritic cells : 25.00% ; Lung-Ciliated cells : 65.95% ; Lung-ATI : 46.31% ; Lung-Fibroblasts : 39.33% ; PBMC-T cells : 39.22% ; Lung-Secretory cells : 38.34% ; Lung-Ciliated cells : 23.26% ; |
|
Human alphaherpesvirus 1 |
Lung-Ciliated cells : 85.61% ; Lung-Mesothelial cells : 84.62% ; Lung-Secretory cells : 79.27% ; Lung-ATI : 67.91% ; Lung-ATII : 60.56% ; Lung-Ciliated cells : 81.30% ; Lung-ATI : 64.69% ; Lung-Dendritic cells : 62.50% ; Lung-Fibroblasts : 60.67% ; Lung-Secretory cells : 54.40% ; Lung-Ciliated cells : 72.18% ; Lung-Secretory cells : 62.69% ; Lung-ATI : 49.53% ; Lung-ATII : 45.17% ; Lung-Dendritic cells : 25.00% ; Lung-Ciliated cells : 51.80% ; Lung-ATII : 27.67% ; Lung-ATI : 25.65% ; Lung-Secretory cells : 24.87% ; Lung-Ciliated cells : 40.77% ; Lung-Mesothelial cells : 23.08% ; |
|
Adeno-associated virus - 2 |
Lung-Ciliated cells : 84.41% ; Lung-ATI : 84.01% ; Lung-Secretory cells : 65.80% ; Lung-ATII : 55.33% ; Lung-Dendritic cells : 50.00% ; Lung-Ciliated cells : 65.95% ; Lung-ATI : 46.31% ; Lung-Fibroblasts : 39.33% ; PBMC-T cells : 39.22% ; Lung-Secretory cells : 38.34% ; Lung-Ciliated cells : 49.16% ; PBMC-DCs : 38.46% ; Lung-B cells : 29.41% ; Lung-Natural killer cells : 27.27% ; Lung-Secretory cells : 26.42% ; Lung-Ciliated cells : 23.26% ; |
|
Simian rotavirus A strain RRV |
Lung-Ciliated cells : 81.30% ; Lung-ATI : 64.69% ; Lung-Dendritic cells : 62.50% ; Lung-Fibroblasts : 60.67% ; Lung-Secretory cells : 54.40% ; Lung-Ciliated cells : 68.35% ; PBMC-B cells : 52.38% ; Lung-Mesothelial cells : 46.15% ; Lung-ATI : 41.43% ; Lung-Fibroblasts : 41.01% ; Lung-Ciliated cells : 67.15% ; Lung-ATI : 58.05% ; Lung-Secretory cells : 33.16% ; Lung-Endothelial cells : 33.08% ; Lung-Fibroblasts : 32.02% ; Lung-Ciliated cells : 65.95% ; Lung-ATI : 46.31% ; Lung-Fibroblasts : 39.33% ; PBMC-T cells : 39.22% ; Lung-Secretory cells : 38.34% ; Lung-Ciliated cells : 61.39% ; Lung-Endothelial cells : 59.76% ; |
|
Human parechovirus 1 |
Lung-Ciliated cells : 81.30% ; Lung-ATI : 64.69% ; Lung-Dendritic cells : 62.50% ; Lung-Fibroblasts : 60.67% ; Lung-Secretory cells : 54.40% ; |
|
Human mastadenovirus C |
Lung-Ciliated cells : 81.30% ; Lung-ATI : 64.69% ; Lung-Dendritic cells : 62.50% ; Lung-Fibroblasts : 60.67% ; Lung-Secretory cells : 54.40% ; Lung-Ciliated cells : 54.92% ; Lung-Mesothelial cells : 38.46% ; Lung-Smooth muscle cells : 36.34% ; Lung-Macrophages : 29.93% ; Lung-Fibroblasts : 25.84% ; Lung-Ciliated cells : 53.24% ; Lung-Mesothelial cells : 30.77% ; Lung-ATI : 27.62% ; Lung-Secretory cells : 23.83% ; |
|
Coxsackievirus A9 | |
|
Coxsackievirus B1 |
Lung-Ciliated cells : 81.30% ; Lung-ATI : 64.69% ; Lung-Dendritic cells : 62.50% ; Lung-Fibroblasts : 60.67% ; Lung-Secretory cells : 54.40% ; Lung-Ciliated cells : 72.18% ; Lung-Secretory cells : 62.69% ; Lung-ATI : 49.53% ; Lung-ATII : 45.17% ; Lung-Dendritic cells : 25.00% ; Lung-Ciliated cells : 53.24% ; Lung-Mesothelial cells : 30.77% ; Lung-ATI : 27.62% ; Lung-Secretory cells : 23.83% ; |
|
West Nile virus |
Lung-Ciliated cells : 81.30% ; Lung-ATI : 64.69% ; Lung-Dendritic cells : 62.50% ; Lung-Fibroblasts : 60.67% ; Lung-Secretory cells : 54.40% ; |
|
Human gammaherpesvirus 8 |
Lung-Ciliated cells : 81.30% ; Lung-ATI : 64.69% ; Lung-Dendritic cells : 62.50% ; Lung-Fibroblasts : 60.67% ; Lung-Secretory cells : 54.40% ; |
|
Xenotropic murine leukemia virus |
Lung-Ciliated cells : 79.38% ; Lung-B cells : 50.00% ; Lung-Endothelial cells : 47.39% ; Lung-Macrophages : 45.18% ; Lung-Fibroblasts : 42.70% ; |
|
Polytropic murine leukemia virus |
Lung-Ciliated cells : 79.38% ; Lung-B cells : 50.00% ; Lung-Endothelial cells : 47.39% ; Lung-Macrophages : 45.18% ; Lung-Fibroblasts : 42.70% ; |
|
Human mastadenovirus B | |
|
Human alphaherpesvirus 3 |
Lung-Dendritic cells : 75.00% ; Lung-Ciliated cells : 71.22% ; Lung-ATI : 50.05% ; Lung-Secretory cells : 49.74% ; Lung-Fibroblasts : 40.45% ; |
|
Varicella Zoster Virus |
Lung-Dendritic cells : 75.00% ; Lung-Ciliated cells : 71.22% ; Lung-ATI : 50.05% ; Lung-Secretory cells : 49.74% ; Lung-Fibroblasts : 40.45% ; |
|
Japanese encephalitis virus | |
|
Coxsackievirus A10 |
Lung-Ciliated cells : 69.30% ; Lung-ATI : 59.29% ; Lung-Secretory cells : 34.20% ; Lung-Fibroblasts : 31.46% ; Lung-Smooth muscle cells : 25.96% ; |
|
Mammalian orthoreovirus | |
|
Feline calicivirus |
Lung-Ciliated cells : 67.15% ; Lung-ATI : 58.05% ; Lung-Secretory cells : 33.16% ; Lung-Endothelial cells : 33.08% ; Lung-Fibroblasts : 32.02% ; |
|
Human rotavirus strain WA |
Lung-Ciliated cells : 67.15% ; Lung-ATI : 58.05% ; Lung-Secretory cells : 33.16% ; Lung-Endothelial cells : 33.08% ; Lung-Fibroblasts : 32.02% ; Lung-Ciliated cells : 65.95% ; Lung-ATI : 46.31% ; Lung-Fibroblasts : 39.33% ; PBMC-T cells : 39.22% ; Lung-Secretory cells : 38.34% ; Lung-Ciliated cells : 61.39% ; Lung-Endothelial cells : 59.76% ; |
|
Hendra henipavirus |
Lung-Ciliated cells : 66.91% ; Lung-Endothelial cells : 65.87% ; Lung-Fibroblasts : 33.71% ; Lung-B cells : 32.35% ; Lung-Macrophages : 30.79% ; |
|
Nipah henipavirus |
Lung-Ciliated cells : 66.91% ; Lung-Endothelial cells : 65.87% ; Lung-Fibroblasts : 33.71% ; Lung-B cells : 32.35% ; Lung-Macrophages : 30.79% ; |
|
Ebola virus |
Lung-Ciliated cells : 66.19% ; Lung-Macrophages : 63.74% ; Lung-Dendritic cells : 62.50% ; Lung-Fibroblasts : 50.56% ; Lung-Endothelial cells : 35.62% ; Lung-Ciliated cells : 41.01% ; Lung-Ciliated cells : 39.57% ; Lung-Dendritic cells : 37.50% ; Lung-Macrophages : 25.32% ; Lung-Smooth muscle cells : 24.83% ; |
|
Marburg marburgvirus | |
|
Equid alphaherpesvirus 1 | |
|
Human metapneumovirus | |
|
Human gammaherpesvirus 4 |
Lung-Ciliated cells : 65.95% ; Lung-ATI : 46.31% ; Lung-Fibroblasts : 39.33% ; PBMC-T cells : 39.22% ; Lung-Secretory cells : 38.34% ; |
|
Human parvovirus B19 | |
|
Echovirus E8 | |
|
Echovirus E1 | |
|
Canine coronavirus |
Lung-Ciliated cells : 62.59% ; Lung-ATII : 51.51% ; Lung-Mesothelial cells : 38.46% ; Lung-Secretory cells : 37.82% ; Lung-Fibroblasts : 32.58% ; |
|
Feline coronavirus |
Lung-Ciliated cells : 62.59% ; Lung-ATII : 51.51% ; Lung-Mesothelial cells : 38.46% ; Lung-Secretory cells : 37.82% ; Lung-Fibroblasts : 32.58% ; |
|
Infectious bronchitis virus |
Lung-Ciliated cells : 62.59% ; Lung-ATII : 51.51% ; Lung-Mesothelial cells : 38.46% ; Lung-Secretory cells : 37.82% ; Lung-Fibroblasts : 32.58% ; |
|
Porcine epidemic diarrhea virus |
Lung-Ciliated cells : 62.59% ; Lung-ATII : 51.51% ; Lung-Mesothelial cells : 38.46% ; Lung-Secretory cells : 37.82% ; Lung-Fibroblasts : 32.58% ; |
|
Human coronavirus 229E |
Lung-Ciliated cells : 62.59% ; Lung-ATII : 51.51% ; Lung-Mesothelial cells : 38.46% ; Lung-Secretory cells : 37.82% ; Lung-Fibroblasts : 32.58% ; |
|
Transmissible gastroenteritis virus |
Lung-Ciliated cells : 62.59% ; Lung-ATII : 51.51% ; Lung-Mesothelial cells : 38.46% ; Lung-Secretory cells : 37.82% ; Lung-Fibroblasts : 32.58% ; |
|
Latino mammarenavirus |
Lung-Ciliated cells : 61.63% ; Lung-ATI : 30.32% ; Lung-Fibroblasts : 24.16% ; Lung-Mesothelial cells : 23.08% ; |
|
Lassa mammarenavirus |
Lung-Ciliated cells : 61.63% ; Lung-ATI : 30.32% ; Lung-Fibroblasts : 24.16% ; Lung-Mesothelial cells : 23.08% ; Lung-Dendritic cells : 50.00% ; Lung-Ciliated cells : 44.12% ; Lung-Ciliated cells : 41.01% ; Lung-Ciliated cells : 39.57% ; Lung-Dendritic cells : 37.50% ; Lung-Macrophages : 25.32% ; Lung-Smooth muscle cells : 24.83% ; |
|
Lymphocytic choriomeningitis mammarenavirus | |
|
Oliveros mammarenavirus |
Lung-Ciliated cells : 61.63% ; Lung-ATI : 30.32% ; Lung-Fibroblasts : 24.16% ; Lung-Mesothelial cells : 23.08% ; |
|
Guanarito mammarenavirus |
Lung-Ciliated cells : 60.91% ; Lung-Dendritic cells : 50.00% ; Lung-Mesothelial cells : 38.46% ; Lung-T cells : 32.79% ; Lung-Secretory cells : 30.05% ; |
|
Argentinian mammarenavirus |
Lung-Ciliated cells : 60.91% ; Lung-Dendritic cells : 50.00% ; Lung-Mesothelial cells : 38.46% ; Lung-T cells : 32.79% ; Lung-Secretory cells : 30.05% ; |
|
Mouse mammary tumor virus |
Lung-Ciliated cells : 60.91% ; Lung-Dendritic cells : 50.00% ; Lung-Mesothelial cells : 38.46% ; Lung-T cells : 32.79% ; Lung-Secretory cells : 30.05% ; |
|
Canine parvovirus |
Lung-Ciliated cells : 60.91% ; Lung-Dendritic cells : 50.00% ; Lung-Mesothelial cells : 38.46% ; Lung-T cells : 32.79% ; Lung-Secretory cells : 30.05% ; |
|
Feline panleukopenia virus |
Lung-Ciliated cells : 60.91% ; Lung-Dendritic cells : 50.00% ; Lung-Mesothelial cells : 38.46% ; Lung-T cells : 32.79% ; Lung-Secretory cells : 30.05% ; |
|
Machupo mammarenavirus |
Lung-Ciliated cells : 60.91% ; Lung-Dendritic cells : 50.00% ; Lung-Mesothelial cells : 38.46% ; Lung-T cells : 32.79% ; Lung-Secretory cells : 30.05% ; |
|
Dengue virus |
Lung-Ciliated cells : 60.67% ; Lung-ATI : 34.48% ; Lung-Macrophages : 32.66% ; Lung-Secretory cells : 32.64% ; Lung-Dendritic cells : 25.00% ; Lung-Ciliated cells : 49.16% ; PBMC-DCs : 38.46% ; Lung-B cells : 29.41% ; Lung-Natural killer cells : 27.27% ; Lung-Secretory cells : 26.42% ; Lung-Ciliated cells : 39.57% ; Lung-Dendritic cells : 37.50% ; Lung-Macrophages : 25.32% ; Lung-Smooth muscle cells : 24.83% ; |
|
Simian sarcoma-associated virus |
Lung-Ciliated cells : 60.19% ; Lung-Mesothelial cells : 38.46% ; Lung-Natural killer cells : 36.36% ; PBMC-NKs : 35.71% ; PBMC-B cells : 33.52% ; |
|
Hepatitis E virus |
Lung-ATI : 54.31% ; Lung-Ciliated cells : 49.40% ; Lung-Fibroblasts : 26.40% ; |
|
Coxsackievirus B5 |
Lung-Ciliated cells : 53.24% ; Lung-Mesothelial cells : 30.77% ; Lung-ATI : 27.62% ; Lung-Secretory cells : 23.83% ; |
|
Human mastadenovirus A |
Lung-Ciliated cells : 53.24% ; Lung-Mesothelial cells : 30.77% ; Lung-ATI : 27.62% ; Lung-Secretory cells : 23.83% ; |
|
Coxsackievirus B2 |
Lung-Ciliated cells : 53.24% ; Lung-Mesothelial cells : 30.77% ; Lung-ATI : 27.62% ; Lung-Secretory cells : 23.83% ; |
|
Human mastadenovirus E |
Lung-Ciliated cells : 53.24% ; Lung-Mesothelial cells : 30.77% ; Lung-ATI : 27.62% ; Lung-Secretory cells : 23.83% ; |
|
Human mastadenovirus F |
Lung-Ciliated cells : 53.24% ; Lung-Mesothelial cells : 30.77% ; Lung-ATI : 27.62% ; Lung-Secretory cells : 23.83% ; |
|
Coxsackievirus B3 |
Lung-Ciliated cells : 53.24% ; Lung-Mesothelial cells : 30.77% ; Lung-ATI : 27.62% ; Lung-Secretory cells : 23.83% ; |
|
Human mastadenovirus D |
Lung-Ciliated cells : 53.24% ; Lung-Mesothelial cells : 30.77% ; Lung-ATI : 27.62% ; Lung-Secretory cells : 23.83% ; |
|
Coxsackievirus B4 |
Lung-Ciliated cells : 53.24% ; Lung-Mesothelial cells : 30.77% ; Lung-ATI : 27.62% ; Lung-Secretory cells : 23.83% ; |
|
Coxsackievirus B6 |
Lung-Ciliated cells : 53.24% ; Lung-Mesothelial cells : 30.77% ; Lung-ATI : 27.62% ; Lung-Secretory cells : 23.83% ; |
|
Bovine leukemia virus |
Lung-Ciliated cells : 53.00% ; PBMC-DCs : 34.62% ; Lung-Natural killer cells : 27.27% ; Lung-Macrophages : 23.45% ; |
|
Human papillomavirus type 16 |
Lung-Ciliated cells : 53.00% ; Lung-Endothelial cells : 36.21% ; Lung-Natural killer cells : 27.27% ; Lung-Mesothelial cells : 23.08% ; |
|
Suid alphaherpesvirus 1 | |
|
Human alphaherpesvirus 2 | |
|
Human rhinovirus A2 |
Lung-Ciliated cells : 50.60% ; Lung-ATII : 38.53% ; Lung-Macrophages : 24.75% ; Lung-Secretory cells : 23.32% ; |
|
Coxsackievirus A21 |
Lung-Dendritic cells : 50.00% ; Lung-Ciliated cells : 35.49% ; |
|
Rhinovirus B14 |
Lung-Dendritic cells : 50.00% ; Lung-Ciliated cells : 35.49% ; |
|
Sindbis virus |
Lung-Ciliated cells : 49.16% ; PBMC-DCs : 38.46% ; Lung-B cells : 29.41% ; Lung-Natural killer cells : 27.27% ; Lung-Secretory cells : 26.42% ; |
|
Venezuelan equine encephalitis virus |
Lung-Ciliated cells : 49.16% ; PBMC-DCs : 38.46% ; Lung-B cells : 29.41% ; Lung-Natural killer cells : 27.27% ; Lung-Secretory cells : 26.42% ; |
|
Classical swine fever virus |
Lung-Ciliated cells : 49.16% ; PBMC-DCs : 38.46% ; Lung-B cells : 29.41% ; Lung-Natural killer cells : 27.27% ; Lung-Secretory cells : 26.42% ; |
|
Adeno-associated virus - 3 |
Lung-Ciliated cells : 49.16% ; PBMC-DCs : 38.46% ; Lung-B cells : 29.41% ; Lung-Natural killer cells : 27.27% ; Lung-Secretory cells : 26.42% ; |
|
Adeno-associated virus 9 |
Lung-Ciliated cells : 49.16% ; PBMC-DCs : 38.46% ; Lung-B cells : 29.41% ; Lung-Natural killer cells : 27.27% ; Lung-Secretory cells : 26.42% ; |
|
Adeno-associated virus - 8 |
Lung-Ciliated cells : 49.16% ; PBMC-DCs : 38.46% ; Lung-B cells : 29.41% ; Lung-Natural killer cells : 27.27% ; Lung-Secretory cells : 26.42% ; |
|
SARS coronavirus |
Lung-Ciliated cells : 41.01% ; |
|
Bovine alphaherpesvirus 1 | |
|
Zika virus |
Lung-Ciliated cells : 39.57% ; Lung-Dendritic cells : 37.50% ; Lung-Macrophages : 25.32% ; Lung-Smooth muscle cells : 24.83% ; |
|
Feline leukemia virus strain C/FA27 |
Lung-Ciliated cells : 36.69% ; |
|
Ecotropic murine leukemia virus |
Lung-Ciliated cells : 36.45% ; Lung-Mesothelial cells : 23.08% ; |
|
Feline immunodeficiency virus |
Lung-Ciliated cells : 31.89% ; Lung-Dendritic cells : 25.00% ; |
|
Human immunodeficiency virus 1 |
Lung-Ciliated cells : 31.89% ; Lung-Dendritic cells : 25.00% ; |
|
Human immunodeficiency virus 2 |
Lung-Ciliated cells : 31.89% ; Lung-Dendritic cells : 25.00% ; |
|
Enterovirus C |
Lung-Dendritic cells : 25.00% ; |
|
Feline endogenous virus RD114 |
Lung-Ciliated cells : 24.46% ; |
|
Baboon endogenous virus strain M7 |
Lung-Ciliated cells : 24.46% ; |
|
Simian type D retrovirus -Tsukuba |
Lung-Ciliated cells : 24.46% ; |
|
Phocine morbillivirus |
Lung-Ciliated cells : 23.50% ; |
|
Canine morbillivirus |
Lung-Ciliated cells : 23.50% ; |
|
Measles morbillivirus |
Lung-Ciliated cells : 23.50% ; |
|
Rinderpest morbillivirus |
Lung-Ciliated cells : 23.50% ; |